NCT06815289View on ClinicalTrials.gov

MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery

NARecruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Primary Lung Cancer or Secondary Lung Metastases
Interventions
RADIATION

MR-informed stereotactic radiotherapy

MR-informed stereotactic radiotherapy for treatment of ultracentral lung tumours utilising a dedicated MR-simulator for daily adaptation followed by CBCT-guided treatment delivery.

Trial Locations (1)

Unknown

RECRUITING

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT06815289 - MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery | Biotech Hunter | Biotech Hunter